EP 3738960 A1 20201118 - HISTONE DEMETHYLASE INHIBITORS
Title (en)
HISTONE DEMETHYLASE INHIBITORS
Title (de)
HISTONDEMETHYLASEINHIBITOREN
Title (fr)
INHIBITEURS DE L'HISTONE DÉMÉTHYLASE
Publication
Application
Priority
- US 201462017201 P 20140625
- EP 15811523 A 20150625
- US 2015037812 W 20150625
Abstract (en)
The present disclosure relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted pyridine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
IPC 8 full level
C07D 401/12 (2006.01); A61K 31/44 (2006.01); A61K 31/4433 (2006.01); A61K 31/4436 (2006.01); A61K 31/4439 (2006.01); A61K 31/4709 (2006.01); A61P 35/00 (2006.01); C07D 213/79 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 409/12 (2006.01); C07D 409/14 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01)
CPC (source: EP KR US)
A61K 31/44 (2013.01 - KR); A61K 31/4433 (2013.01 - KR); A61P 35/00 (2017.12 - EP US); C07D 213/79 (2013.01 - EP KR US); C07D 401/12 (2013.01 - EP KR US); C07D 403/12 (2013.01 - KR US); C07D 403/14 (2013.01 - US); C07D 405/12 (2013.01 - EP KR US); C07D 405/14 (2013.01 - EP US); C07D 409/12 (2013.01 - EP US); C07D 409/14 (2013.01 - EP US); C07D 413/12 (2013.01 - EP KR US); C07D 417/12 (2013.01 - EP KR US); C07D 417/14 (2013.01 - EP US)
Citation (applicant)
- BERGE S.M. ET AL.: "Pharmaceutical Salts", JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 66, 1997, pages 1 - 19, XP002675560, DOI: 10.1002/jps.2600660104
- BUNDGARD, H.: "Design of Prodrugs", 1985, ELSEVIER, pages: 7 - 9,21-24
- HIGUCHI, T. ET AL.: "Pro-drugs as Novel Delivery Systems", A.C.S. SYMPOSIUM SERIES, vol. 14
- "Bioreversible Carriers in Drug Design", 1987, AMERICAN PHARMACEUTICAL ASSOCIATION AND PERGAMON PRESS
- S. R. SANDLER ET AL.: "Organic Functional Group Preparations", 1983, JOHN WILEY & SONS, INC.
- H. O. HOUSE: "Modern Synthetic Reactions", 1972, W. A. BENJAMIN, INC.
- T. L. GILCHRIST: "Advanced Organic Chemistry: Reactions, Mechanisms, and Structure", 1992, WILEY-INTERSCIENCE
- FUHRHOP, J.PENZLIN G.: "Second, Revised and Enlarged Edition", 1994, JOHN WILEY & SONS, article "Organic Synthesis: Concepts, Methods, Starting Materials"
- HOFFMAN, R.V.: "Organic Chemistry, An Intermediate Text", 1996, OXFORD UNIVERSITY PRESS
- LAROCK, R. C.: "Industrial Organic Chemicals: Starting Materials and Intermediates: An Ullmann's Encyclopedia", vol. 8, 1999, JOHN WILEY & SONS
- SOLOMONS, T. W. G.: "Modern Carbonyl Chemistry", 2000, JOHN WILEY & SONS
- STOWELL, J.C.: "Intermediate Organic Chemistry", 1993, WILEY-INTERSCIENCE
- "Organic Reactions", vol. 55, 1942, JOHN WILEY & SONS
- P. H. STAHLC. G. WERMUTH: "Handbook of Pharmaceutical Salts", vol. 73, 2002, VERLAG HELVETICA CHIMICA ACTA
- MARGUERON ET AL., CURR. OPIN. GENET. DEV., vol. 15, 2005, pages 163 - 176
- LACHNER ET AL., J. CELL SCI., vol. 116, 2003, pages 2117 - 2124
- KLOSE ET AL., NATURE REVIEWS/GENETICS, vol. 7, 2006, pages 715 - 727
- LIN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 108, no. 33, 16 August 2011 (2011-08-16), pages 13379 - 86
Citation (search report)
- [AP] WO 2014100818 A1 20140626 - QUANTICEL PHARMACEUTICALS INC [US]
- [A] WO 2013143597 A1 20131003 - GLAXO GROUP LTD [GB], et al
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
US 2015376169 A1 20151231; US 9242968 B2 20160126; AR 100997 A1 20161116; AU 2015279719 A1 20170202; AU 2015279719 B2 20190321; BR 112016030367 A2 20180717; CA 2953437 A1 20151230; CA 2953437 C 20220830; CL 2016003301 A1 20210305; CN 106660982 A 20170510; CN 106660982 B 20200908; CN 111909083 A 20201110; CN 111909083 B 20230815; CO 2017000359 A2 20170410; CY 1123906 T1 20220527; DK 3160952 T3 20210308; EA 031200 B1 20181130; EA 201692483 A1 20170531; EC SP17004931 A 20170331; EP 3160952 A1 20170503; EP 3160952 A4 20180221; EP 3160952 B1 20201202; EP 3738960 A1 20201118; EP 3741749 A1 20201125; ES 2862648 T3 20211007; HR P20210299 T1 20210416; HU E053876 T2 20210728; IL 249629 A0 20170228; JP 2017523152 A 20170817; JP 6521535 B2 20190529; KR 102591897 B1 20231019; KR 20170018079 A 20170215; LT 3160952 T 20210510; MX 2016017407 A 20170427; NZ 728120 A 20230630; PL 3160952 T3 20210719; PT 3160952 T 20210308; SA 516380585 B1 20201206; SG 11201610813T A 20170127; SI 3160952 T1 20210730; TW 201613882 A 20160416; TW 202124369 A 20210701; TW I715533 B 20210111; TW I758004 B 20220311; US 10106534 B2 20181023; US 10385047 B2 20190820; US 2016107995 A1 20160421; US 2016332970 A1 20161117; US 2017114055 A1 20170427; US 2017158685 A1 20170608; US 2018044334 A1 20180215; US 2018251458 A1 20180906; US 9447046 B2 20160920; US 9586902 B2 20170307; US 9815828 B2 20171114; US 9994561 B2 20180612; WO 2015200709 A1 20151230
DOCDB simple family (application)
US 201514751007 A 20150625; AR P150102042 A 20150625; AU 2015279719 A 20150625; BR 112016030367 A 20150625; CA 2953437 A 20150625; CL 2016003301 A 20161222; CN 201580045921 A 20150625; CN 202010813617 A 20150625; CO 2017000359 A 20170116; CY 211100169 T 20210301; DK 15811523 T 20150625; EA 201692483 A 20150625; EC PI201704931 A 20170124; EP 15811523 A 20150625; EP 20184106 A 20150625; EP 20184107 A 20150625; ES 15811523 T 20150625; HR P20210299 T 20210223; HU E15811523 A 20150625; IL 24962916 A 20161218; JP 2016574454 A 20150625; KR 20177002223 A 20150625; LT 15811523 T 20150625; MX 2016017407 A 20150625; NZ 72812015 A 20150625; PL 15811523 T 20150625; PT 15811523 T 20150625; SA 516380585 A 20161222; SG 11201610813T A 20150625; SI 201531524 T 20150625; TW 104120633 A 20150625; TW 109143458 A 20150625; US 2015037812 W 20150625; US 201514963754 A 20151209; US 201515321702 A 20150625; US 201615220118 A 20160726; US 201715402100 A 20170109; US 201715792570 A 20171024; US 201815971749 A 20180504